Abstract:BackgroundTargeting ubiquitin-dependent proteolysis is one of the strategies in cancer therapy. CRLCDT2 and CRLDDB2 are two key E3 ubiquitin ligases involved in DNA replication and DNA damage repair. But CDT2 and DDB2 are opposite prognostic factors in kinds of cancers, and the underlining mechanism needs to be elucidated.MethodsSmall interfering RNAs were used to determine the function of target genes. Co-immunoprecipitation (Co-IP) was performed to detect the interaction between DDB2 and CDT2. Immunofluorescence assays and fluorescence activating cell sorting (FACS) were used to measure the change of DNA content. In vivo ubiquitination assay was carried out to clarify the ubiquitination of CDT2 mediated by DDB2. Cell synchronization was performed to arrest cells at G1/S and S phase. The mechanism involved in DDB2-mediated CDT2 degradation was investigated by constructing plasmids with mutant variants and measured by Western blot. Immunohistochemistry was performed to determine the relationship between DDB2 and CDT2. Paired two-side Student's t-test was used to measure the significance of the difference between control group and experimental group.ResultsKnockdown of DDB2 stabilized CDT2, while over-expression of DDB2 enhanced ubiquitination of CDT2, and subsequentially degradation of CDT2. Although both DDB2 and CDT2 contain PIP (PCNA-interacting protein) box, PIP box is dispensable for DDB2-mediated CDT2 degradation. Knockdown of PCNA had negligible effects on the stability of CDT2, but promoted accumulation of CDT1, p21 and SET8. Silencing of DDB2 arrested cell cycle in G1 phase, destabilized CDT1 and reduced the chromatin loading of MCMs, thereby blocked the formation of polyploidy induced by ablation of CDT2. In breast cancer and ovarian teratoma tissues, high level of DDB2 was along with lower level of CDT2.ConclusionsWe found that CRL4(DDB2) is the novel E3 ubiquitin ligases of CDT2, and DDB2 regulates DNA replication through indirectly regulates CDT1 protein stability by degrading CDT2 and promotes the assembly of pre-replication complex. Our results broaden the horizon for understanding the opposite function of CDT2 and DDB2 in tumorigenesis, and may provide clues for drug discovery in cancer therapy.

CDK11p58 Represses Vitamin D Receptor-Mediated Transcriptional Activation Through Promoting Its Ubiquitin–proteasome Degradation

Repression of Estrogen Receptor Alpha by CDK11p58 Through Promoting Its Ubiquitin-Proteasome Degradation.

Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity.

Abnormal Expression of CDK11 P58 in Prostate Cancer

CDK11 P58 Inhibits ERα-positive Breast Cancer Invasion by Targeting Integrin Β3 Via the Repression of ERα Signaling

CDK11 p58 protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway

CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.

Cyclin D3/CDK11(p58) Complex is Involved in the Repression of Androgen Receptor

Cyclin-dependent Kinase 11(p58) Interacts with HBO1 and Enhances Its Histone Acetyltransferase Activity.

Cdkn1c (p57(kip2)) is A Direct Target of Ezh2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells

Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis

Vitamin D Receptor Inhibits Nuclear Factor Κb Activation by Interacting with IκB Kinase Β Protein

Negative Regulation Of Hdm2 To Attenuate P53 Degradation By Ribosomal Protein L26

DDX21 Interacts with WDR5 to Promote Colorectal Cancer Cell Proliferation by Activating CDK1 Expression

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.

Thr-370 is Responsible for Cdk11(P58) Autophosphorylation, Dimerization, and Kinase Activity

Critical Role of CDK11p58 in Human Breast Cancer Growth and Angiogenesis

DDB2 Regulates DNA Replication Through PCNA-independent Degradation of CDT2

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

Rbb, A Novel Transcription Repressor, Represses the Transcription of Hdm2 Oncogene